Zavesca er undersøgt for indikationer, hvor visse hændelser rapporteret som bivirkninger, som f. eks. neurologiske symptomer/ tegn og trombocytopeni, også kunne skyldes den underliggende sygdomme.
Zavesca has been studied in indications where certain events reported as adverse drug reactions, such as neurological symptoms/ signs and thrombocytopenia could also be due to the underlying conditions.